Filter
261
Text search:
European
Association
for
the
Study
of
the
Liver
Featured
37
56
Language
Document type
146
46
43
9
7
5
4
1
Countries / Regions
17
16
9
8
6
5
5
5
4
4
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
65
61
16
11
5
5
4
Toolboxes
35
26
16
16
11
11
10
8
7
7
6
5
5
2
2
1
1
1
1
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
The Health Systems in Transition (HiT) series consists of country-based reviews that provide a detailed description of a health system and
...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time
...
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public hea
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in th
...
This summary covers the preventive approach to breast cancer control and includes prophylactic medications, prophylactic surgery and lifestyle modifications for breast cancer prevention. Health prof
...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of
...
In Climate Change 2014: Impacts, Adaptation, and Vulnerability. Part A: Global and Sectoral Aspects. Contribution of Working Group II to the Fifth Assessment Report
...
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Handbook For Clinical Management Of Dengue
recommended
Clinical management handbook
Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.
Cancer, diabetes, heart disease and stroke, chronic respiratory disease
Therapeutics Information and Pharmacovigilance Centre | TIPC
